FDA issued a Warning Letter to Kolmar Korea Co. Ltd. on 5/18/2018 as a result of this inspection.
FDA investigators audited the Kolmar Korea - Sejong-si, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 28 Sep 2017.
Add To Cart
- Category: Human Drugs
- Inspection end: 28 Sep 2017
- Location: Sejong-si, Korea (the Republic of)
- FEI: 3004033751